The World of Health & Medicine News

Study Finds CGMs Could Overestimate Food’s Impact on Blood Sugar Among Nondiabetic Individuals

Study Finds CGMs Could Overestimate Food’s Impact on Blood Sugar Among Nondiabetic Individuals

 CGMs may inaccurately estimate blood sugar levels in healthy individuals, leading to unnecessary dietary changes.

  • Discrepancies arise because CGMs measure glucose in interstitial fluid, not directly in blood, causing potential errors

As continuous glucose monitors (CGMs) become more widely used to help manage blood sugar levels in individuals with diabetes, findings from the University of Bath suggest that these devices may not be as accurate as commonly believed. The study authors, who published their results in The American Journal of Clinical Nutrition, noted that CGMs could be overestimating blood sugar levels in healthy adults that are using these devices to track how different foods affect their glucose levels, leading to unnecessary diet changes.

CGMs are fantastic tools for people with diabetes because even if a measurement isn’t perfectly accurate, it’s still better than not having a measurement at all. However, for someone with good glucose control, they can be misleading based on their current performance. For healthy individuals, relying on CGMs could lead to unnecessary food restrictions or poor dietary choices,” Javier Gonzalez, PhD, professor at the University of Bath, said in a news release

spot_img

Explore more

spot_img

GSK wins US approval for twice-yearly asthma drug

GSK wins US approval for twice-yearly asthma drug  The U.S. health regulator has approved GSK's (GSK.L), opens new tab add-on treatment for severe asthma, offering a less...

US CDC ends guidance that all newborns should get hepatitis B...

US CDC ends guidance that all newborns should get hepatitis B vaccine, in major policy shift The U.S. Centers for Disease Control and Prevention on...

FDA Approves J&J’s Akeega for Expanded Use in Prostate Cancer

FDA Approves J&J's Akeega for Expanded Use in Prostate Cancer Johnson & Johnson JNJ announced that the FDA approved its precision therapy, Akeega (niraparib and abiraterone acetate...

Women are increasingly using steroids — despite these 7 major risks

Women are increasingly using steroids — despite these 7 major risks As fitfluencers push powerlifting, weight training and “whatever it takes” to get toned, more women...

Kyverna’s cell therapy helps patients improve mobility in mid-stage trial

Kyverna's cell therapy helps patients improve mobility in mid-stage trial Kyverna Therapeutics said its experimental cell therapy met the main goal of “significantly” improving patients’...

AstraZeneca, Daiichi’s breast cancer drug gets FDA nod as first-line treatment

AstraZeneca, Daiichi's breast cancer drug gets FDA nod as first-line treatment The U.S. Food and Drug ​Administration has approved ‌Daiichi Sankyo's therapy in combination ‌with...

WHO expert group’s new analysis reaffirms there is no link between...

WHO expert group’s new analysis reaffirms there is no link between vaccines and autism new analysis from a WHO global expert committee on vaccine safety...

US FDA expands use of GSK’s Blujepa as treatment for gonorrhea

US FDA expands use of GSK's Blujepa as treatment for gonorrhea The U.S. Food and Drug Administration said on Thursday it has expanded the use...